Kytx investor notice: robbins geller rudman & dowd llp announces that kyverna therapeutics, inc. investors with substantial losses have opportunity to lead investor class action lawsuit

San diego, jan. 08, 2025 (globe newswire) -- the law firm of robbins geller rudman & dowd llp announces that purchasers or acquirers of kyverna therapeutics, inc. (nasdaq: kytx) common stock pursuant and/or traceable to kyverna's registration statement issued in connection with kyverna's initial public offering (“ipo”) held on february 8, 2024, have until friday, february 7, 2025 to seek appointment as lead plaintiff of the kyverna class action lawsuit. captioned rondini v. kyverna therapeutics, inc., no. 24-cv-08869 (n.d. cal.), the kyverna class action lawsuit charges kyverna and certain of kyverna's top current and former executives and directors, as well as certain underwriters of kyverna's ipo with violations of the securities act of 1933.
KYTX Ratings Summary
KYTX Quant Ranking